Read more
In A Fair Trial: The Foundations of Breast Cancer, author Dr. Steven Narod uses knowledge and expertise amassed from his career as a physician and breast cancer researcher to deliver keen insight into the many paradoxes that arise when health care professionals attempt to predict the course of breast cancer treatment. Applying decades of careful observation and study of patients, A Fair Trial goes beyond conventional thinking to explain the variation in cancer outcomes. Readers familiar with cancer treatment may be surprised by the results. A Fair Trial is a touchstone for other scientists and physicians to question the current paradigms of breast cancer screening and treatment and will lead to new ideas that will help physicians, researchers, and patients move forward towards a cure.
About the author
Dr. Steven Narod is an internationally renowned physician and scholar who has devoted his career to improving the lives of women with breast cancer and those at high risk of developing breast cancer. He is a professor at the Dalla Lana School of Public Health at the University of Toronto and the head of the Familial Breast Cancer Clinic at Women's College Hospital. Co-discoverer of the BRCA1 and BRCA2 genes, Dr. Narod has authored over five hundred articles on diverse breast cancer topics, including genetic susceptibility to breast cancer, mammographic screening, breast cancer in young women, and early forms of breast cancer including DCIS (ductal carcinoma in situ). He is often invited to lecture on these topics at conferences around the world, and he has received several prestigious awards for his work, including the McLaughlin Medal from the Royal Society of Canada, the Killam Prize from the Canada Council for the Arts, and the Lifetime Achievement Award from the Canadian Society of Epidemiology and Biostatistics. Dr. Narod was recently awarded the outstanding alumnus award from his alma mater, the University of British Columbia, where he received his MD in 1979. He has held the Canada Research Chair in Breast Cancer for the past twenty-one years.
